脂肪细胞来源的干细胞条件培养基在休止期排尿中的作用。

IF 1.7 Q4 CELL BIOLOGY
Stem Cells and Cloning-Advances and Applications Pub Date : 2023-11-20 eCollection Date: 2023-01-01 DOI:10.2147/SCCAA.S432179
Shadi Zari
{"title":"脂肪细胞来源的干细胞条件培养基在休止期排尿中的作用。","authors":"Shadi Zari","doi":"10.2147/SCCAA.S432179","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To assess the effectiveness of adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) formulation in telogen effluvium patients.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted at a dermatology clinic in Jeddah, Saudi Arabia. The study included 50 consecutive patients aged 20-70 years, who were diagnosed with telogen effluvium. All patients received five monthly sessions of the same commercial ADSC-CM formulation, using a standardized application protocol. Pre- and post-intervention changes in trichometry parameters were analyzed.</p><p><strong>Results: </strong>There was a significant increase in mean hair density (up to 29.01 hair/cm<sup>2</sup>; effect size 0.7-1.0), cumulative hair thickness (up to 2.67 units; effect size 0.7-1.4), and the number of follicular hair units (up to 19.96%; effect size 1.0-1.3) in all scalp regions (p < 0.001), associated with a decrease in mean trichometry-derived Sinclair scale by 0.8-1.3 (p < 0.001). Positive outcomes were observed in 70%-92% of the patients depending on the parameter and scalp region. There was no impact of the patient's age on ADSC-CM efficacy.</p><p><strong>Conclusion: </strong>ADSC-CM was successfully applied as a new treatment option for patients with telogen effluvium. These findings provide another therapeutic and research area for dermatologists to optimize the management of telogen effluvium and reduce its impact on patients.</p>","PeriodicalId":44934,"journal":{"name":"Stem Cells and Cloning-Advances and Applications","volume":"16 ","pages":"77-89"},"PeriodicalIF":1.7000,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675655/pdf/","citationCount":"0","resultStr":"{\"title\":\"Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium.\",\"authors\":\"Shadi Zari\",\"doi\":\"10.2147/SCCAA.S432179\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To assess the effectiveness of adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) formulation in telogen effluvium patients.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted at a dermatology clinic in Jeddah, Saudi Arabia. The study included 50 consecutive patients aged 20-70 years, who were diagnosed with telogen effluvium. All patients received five monthly sessions of the same commercial ADSC-CM formulation, using a standardized application protocol. Pre- and post-intervention changes in trichometry parameters were analyzed.</p><p><strong>Results: </strong>There was a significant increase in mean hair density (up to 29.01 hair/cm<sup>2</sup>; effect size 0.7-1.0), cumulative hair thickness (up to 2.67 units; effect size 0.7-1.4), and the number of follicular hair units (up to 19.96%; effect size 1.0-1.3) in all scalp regions (p < 0.001), associated with a decrease in mean trichometry-derived Sinclair scale by 0.8-1.3 (p < 0.001). Positive outcomes were observed in 70%-92% of the patients depending on the parameter and scalp region. There was no impact of the patient's age on ADSC-CM efficacy.</p><p><strong>Conclusion: </strong>ADSC-CM was successfully applied as a new treatment option for patients with telogen effluvium. These findings provide another therapeutic and research area for dermatologists to optimize the management of telogen effluvium and reduce its impact on patients.</p>\",\"PeriodicalId\":44934,\"journal\":{\"name\":\"Stem Cells and Cloning-Advances and Applications\",\"volume\":\"16 \",\"pages\":\"77-89\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675655/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem Cells and Cloning-Advances and Applications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/SCCAA.S432179\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cells and Cloning-Advances and Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/SCCAA.S432179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评价脂肪细胞源性间充质干细胞条件培养基(ADSC-CM)制剂治疗休止期排尿患者的疗效。方法:在沙特阿拉伯吉达的一家皮肤科诊所进行回顾性队列研究。该研究包括50名年龄在20-70岁之间的连续患者,他们被诊断为休止期排尿。所有患者每月接受5次相同的商业ADSC-CM配方,使用标准化的应用方案。分析干预前和干预后tricometry参数的变化。结果:平均发密度显著增加(达29.01根/cm2;效应量0.7-1.0),累积毛发厚度(可达2.67单位;效应量0.7-1.4),毛囊单位数(高达19.96%;所有头皮区域的效应量1.0-1.3)(p < 0.001),与平均trichometry衍生的Sinclair量表降低0.8-1.3 (p < 0.001)相关。根据参数和头皮区域的不同,70%-92%的患者观察到阳性结果。患者年龄对ADSC-CM疗效无影响。结论:ADSC-CM作为一种新的治疗方案成功应用于休止期排尿患者。这些发现为皮肤科医生提供了另一个治疗和研究领域,以优化休止期排出物的管理并减少其对患者的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium.

Objectives: To assess the effectiveness of adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) formulation in telogen effluvium patients.

Methods: A retrospective cohort study was conducted at a dermatology clinic in Jeddah, Saudi Arabia. The study included 50 consecutive patients aged 20-70 years, who were diagnosed with telogen effluvium. All patients received five monthly sessions of the same commercial ADSC-CM formulation, using a standardized application protocol. Pre- and post-intervention changes in trichometry parameters were analyzed.

Results: There was a significant increase in mean hair density (up to 29.01 hair/cm2; effect size 0.7-1.0), cumulative hair thickness (up to 2.67 units; effect size 0.7-1.4), and the number of follicular hair units (up to 19.96%; effect size 1.0-1.3) in all scalp regions (p < 0.001), associated with a decrease in mean trichometry-derived Sinclair scale by 0.8-1.3 (p < 0.001). Positive outcomes were observed in 70%-92% of the patients depending on the parameter and scalp region. There was no impact of the patient's age on ADSC-CM efficacy.

Conclusion: ADSC-CM was successfully applied as a new treatment option for patients with telogen effluvium. These findings provide another therapeutic and research area for dermatologists to optimize the management of telogen effluvium and reduce its impact on patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.50
自引率
0.00%
发文量
10
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信